Are we getting better at treating COVID-19?

Independent Consultant

John is an independent consultant who has spent 37 years in the life industry, including 17 years at Canada Life and more recently 8 years at Zurich Insurance Group, where he was part of the team that established its corporate risk business, now well established in the market. Following that he was Head of the Life Pricing team at Zurich for 5 years, overseeing a wide range of wealth and protection propositions.

At Zurich he helped establish its small pension scheme longevity swap proposition, which involved setting up simultaneous reinsurance transactions to mirror the client contracts. He has most recently continued with this line of interest as a consultant, supporting Lloyds Banking Group in establishing its first longevity swap transactions.

John is a Fellow of the Institute of Actuaries.

Actuary & Director - Willis Towers Watson

Matthew Edwards is an actuary working at Willis Towers Watson, where he leads the life insurance practice’s demographic risk work, focusing on mortality, longevity and associated analytics.

He has a particular interest in the interface between actuarial work and medical science.

Before his (circa) twenty years at Willis Towers Watson (via legacy Watsons and Towers Watson), he worked for Aviva, including several years in Italy, and for the Actuarial Education Company tutoring life and mortality courses.

He is Chair of the CMI, Editor of the IFoA’s Longevity Bulletin and chaired the profession’s Antibiotic Resistance Working Party.